Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma

Journal of Surgical Oncology

Volumn 107, Issue 4, 2013, Pages 402-407

  Hirashima, Kotaro ^a,b   Iyama, Ken Ichi ^b   Baba, Yoshifumi ^a,b   Honda, Yumi ^b   Sado, Yoshikazu ^c   Ninomiya, Yoshifumi ^d   Watanabe, Masayuki ^a   Takamori, Hiroshi ^a   Beppu, Toru ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c Shigei Medical Research Institute   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

basement membrane; extrahepatic bile duct carcinoma; prognosis; type IV collagen

Indexed keywords

CANSTATIN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA6 CHAIN; KI 67 ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

AGED; ARTICLE; BASEMENT MEMBRANE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURGERY; DOWN REGULATION; EXTRAHEPATIC BILE DUCT CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TUMOR CLASSIFICATION;

AGED; ANALYSIS OF VARIANCE; BASEMENT MEMBRANE; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CARCINOMA; COLLAGEN TYPE IV; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874268491     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23225     Document Type: Article

References (23)

1. Liotta LA, Rao CN, Barsky SH:, Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 636-649.
2. Roahrbach D, Timpl R:, Molecular and cellular aspects of basement membrane. San Diego: Academic Press; 1993; 1-437.
3. Kalluri R:, Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003; 3: 422-433.
4. Blood CH, Zetter BR:, Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
5. Sado Y, Kagawa M, Naito I, et al.: Organization and expression of basement membrane collagen IV genes and their roles in human disorders. J Biochem 1998; 123: 767-776.
6. Mariyama M, Leinonen A, Mochizuki T, et al.: Complete primary structure of the human alpha 3(IV) collagen chain. Coexpression of the alpha 3(IV) and alpha 4(IV) collagen chains in human tissues. J Biol Chem 1994; 269: 23013-23017.
7. Ninomiya Y, Kagawa M, Iyama K, et al.: Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 1995; 130: 1219-1229.
8. Simoneau A, Herring-Gillam FE, Vachon PH, et al.: Identification, distribution, and tissular origin of the alpha5(IV) and alpha6(IV) collagen chains in the developing human intestine. Dev Dyn 1998; 212: 437-447.
9. Hiki Y, Iyama K, Tsuruta J, et al.: Differential distribution of basement membrane type IV collagen alpha1(IV), alpha2(IV), alpha5(IV) and alpha6(IV) chains in colorectal epithelial tumors. Pathol Int 2002; 52: 224-233.
10. Ikeda K, Iyama K, Ishikawa N, et al.: Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol 2006; 168: 856-865.
11. Sado Y, Kagawa M, Kishiro Y, et al.: Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol 1995; 104: 267-275.
12. Nakano S, Iyama K, Ogawa M, et al.: Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha5(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Lab Invest 1999; 79: 281-292.
13. Nakano KY, Iyama KI, Mori T, et al.: Loss of alveolar basement membrane type IV collagen alpha3, alpha4, and alpha5 chains in bronchioloalveolar carcinoma of the lung. J Pathol 2001; 194: 420-427.
14. Misumi S, Iyama K, Honda Y, et al.: Differential expression of basement membrane type-IV collagen alpha1, alpha2, alpha5 and alpha6 chains among the histological subtypes of adenoid cystic carcinoma. Virchows Arch 2004; 445: 54-62.
15. Baba Y, Iyama K, Ikeda K, et al.: The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2008; 15: 555-565.
16. Baba Y, Iyama K, Ikeda K, et al.: Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions. J Gastroenterol 2007; 42: 874-880.
17. Ortega N, Werb Z:, New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci 2002; 115: 4201-4214.
18. Tamamura R, Nagatsuka H, Siar CH, et al.: Differential expression of basement membrane collagen-IV alpha1 to alpha6 chains during oral carcinogenesis. Virchows Arch 2006; 449: 358-366.
19. Lane DP:, Cancer, p53, guardian of the genome. Nature 1992; 358: 15-16.
20. Cheng Q, Luo X, Zhang B, et al.: Distal bile duct carcinoma: Prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 2007; 14: 1212-1219.
21. Rijken AM, Offerhaus GJ, Polak MM, et al.: p53 Expression as a prognostic determinant in resected distal bile duct carcinoma. Eur J Surg Oncol 1999; 25: 297-301.
22. Ajiki T, Kamigaki T, Hasegawa Y, et al.: Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Hepatogastroenterology 2001; 48: 1266-1270.
23. Murakami M, Sasaki T, Kuwada Y, et al.: Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma. Oncol Rep 2003; 10: 1091-1096.